Grace R. Anderson

1.5k total citations
13 papers, 763 citations indexed

About

Grace R. Anderson is a scholar working on Molecular Biology, Oncology and Small Animals. According to data from OpenAlex, Grace R. Anderson has authored 13 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Small Animals. Recurrent topics in Grace R. Anderson's work include Protein Degradation and Inhibitors (4 papers), Mitochondrial Function and Pathology (2 papers) and CAR-T cell therapy research (2 papers). Grace R. Anderson is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Mitochondrial Function and Pathology (2 papers) and CAR-T cell therapy research (2 papers). Grace R. Anderson collaborates with scholars based in United States, France and India. Grace R. Anderson's co-authors include Kris C. Wood, Peter Winter, Donald P. McDonnell, Kevin Lin, Merve Çakır, Suzanne E. Wardell, Colin A. Martz, Elizabeth M. Stein, Abigail Xie and Jeff S. Jasper and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Grace R. Anderson

12 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grace R. Anderson United States	11	573	210	190	123	63	13	763
Ali E. Yesilkanal United States	8	491 0.9×	205 1.0×	146 0.8×	81 0.7×	76 1.2×	10	733
Neil MacLean Canada	17	588 1.0×	155 0.7×	253 1.3×	167 1.4×	68 1.1×	38	816
Shengyan Xiang United States	16	765 1.3×	109 0.5×	273 1.4×	134 1.1×	69 1.1×	25	919
Valentina Serafin Italy	14	545 1.0×	294 1.4×	162 0.9×	96 0.8×	56 0.9×	28	783
Isabella Pallavicini Italy	16	715 1.2×	291 1.4×	273 1.4×	232 1.9×	61 1.0×	20	1.0k
Shilpi Arora United States	15	680 1.2×	262 1.2×	260 1.4×	71 0.6×	98 1.6×	31	948
Andrea Ghelli Luserna di Rorà Italy	13	513 0.9×	98 0.5×	303 1.6×	115 0.9×	64 1.0×	38	735
Ana Slipicevic Norway	15	623 1.1×	152 0.7×	311 1.6×	61 0.5×	62 1.0×	37	823
Víctor J. Sánchez‐Arévalo Lobo Spain	14	693 1.2×	152 0.7×	311 1.6×	65 0.5×	44 0.7×	23	887
Jo Ishizawa United States	18	664 1.2×	129 0.6×	248 1.3×	252 2.0×	73 1.2×	65	892

Countries citing papers authored by Grace R. Anderson

Since Specialization

Citations

This map shows the geographic impact of Grace R. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace R. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace R. Anderson more than expected).

Fields of papers citing papers by Grace R. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace R. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace R. Anderson. The network helps show where Grace R. Anderson may publish in the future.

Co-authorship network of co-authors of Grace R. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Grace R. Anderson. A scholar is included among the top collaborators of Grace R. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace R. Anderson. Grace R. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Smith, Matthew Lee, et al.. (2024). Stand-Capable Workstations Reduce Occupational Sedentary Time Among Administrative Workers. PubMed. 12(3). 162–174.

Joh, Daniel Y., Jacob T. Heggestad, Shengwei Zhang, et al.. (2021). Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates. npj Breast Cancer. 7(1). 85–85. 12 indexed citations

Kim, Ye‐Jin, Tiffany Tsang, Grace R. Anderson, Jessica M. Posimo, & Donita C. Brady. (2020). Inhibition of BCL2 Family Members Increases the Efficacy of Copper Chelation in BRAFV600E-Driven Melanoma. Cancer Research. 80(7). 1387–1400. 38 indexed citations

Lin, Kevin, Justine C. Rutter, Abigail Xie, et al.. (2020). Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer. Nature Genetics. 52(4). 408–417. 39 indexed citations

Manzari, Mandana T., Grace R. Anderson, Kevin Lin, et al.. (2019). Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. Science Advances. 5(9). eaaw9162–eaaw9162. 13 indexed citations

Sammons, Sarah, Grace R. Anderson, Suzanne E. Wardell, et al.. (2019). Combination mTORC1/2 and BCL- X_L inhibition in endocrine and CDK4/6-resistant estrogen receptor-positive breast cancer.. Journal of Clinical Oncology. 37(15_suppl). e14653–e14653. 2 indexed citations

Soderquist, Ryan S., Lorin Crawford, Esther Liu, et al.. (2018). Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity. Nature Communications. 9(1). 3513–3513. 90 indexed citations

Anderson, Grace R., Suzanne E. Wardell, Merve Çakır, et al.. (2018). Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors. Nature Communications. 9(1). 1677–1677. 111 indexed citations

Ali, Moiez, Erin Kaltenbrun, Grace R. Anderson, et al.. (2017). Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance. Nature Communications. 8(1). 15617–15617. 33 indexed citations

10.

Lin, Kevin, Peter Winter, Abigail Xie, et al.. (2016). Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia. Scientific Reports. 6(1). 27696–27696. 136 indexed citations

11.

Park, Sung Hee, Ching‐yi Chang, Rachid Safi, et al.. (2016). ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer. Cell Reports. 15(2). 323–335. 112 indexed citations

12.

Anderson, Grace R., Suzanne E. Wardell, Merve Çakır, et al.. (2016). PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. Science Translational Medicine. 8(369). 369ra175–369ra175. 42 indexed citations

13.

Martz, Colin A., Kathleen Ottina, Katherine R. Singleton, et al.. (2014). Systematic identification of signaling pathways with potential to confer anticancer drug resistance. Science Signaling. 7(357). ra121–ra121. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact